Key points: Orforglipron, a once-daily non-peptide oral GLP-1 pill, has shown weight loss results similar to peptide-based GLP-1 medications in early clinical trial data
In addition, long- and short-term creatine supplementation has been shown to increase muscle mass (and potentially reduce fat mass) in active individuals [7]
Diabetic patients taking Ozempic, metformin, and other diabetes medications are also at risk of hypoglycemia (low blood sugar)
People with type 2 diabetes may see particular benefit
Lose 11-20% of your weight with GLP-1s Medication plus the support you need to reach your goals Message your care team whenever, wherever Progress tracking tools On-demand coaching and support Regular check-ins to keep you on track Refills made simple Average weight loss in 1 year is 11-20% (vs ~2-3% with diet and exercise alone)
Semaglutide and Your Health Journey It's important to note that while Semaglutide can be a game-changer in your weight loss journey, it's not a standalone solution